Home › Research › Risk factors
Effects of structural and social determinants of health and comorbidities on ethno‐racial differences in ATN plasma biomarkers of Alzheimer’s disease: A HABS‐HD study
Karin L. Meeker, Beau M. Ances, Melissa E. Petersen, Robert C. Barber, Kristine S. Yaffe, Zhengyang Zhou, Jorge J. Llibre‐Guerra, Fan Zhang et al.. Alzheimer s & Dementia, 2023-12-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Abstract Background Ethno‐racial differences are observed in amyloid (A), tau (T), and neurodegeneration (N) plasma biomarkers of Alzheimer’s disease (AD). In neuroimaging studies, structural and social determinant of health (SSDOH) factors and associated health outcomes may mediate observed racial differences in neurodegeneration markers. However, little is known regarding the potential effects of SSDOH and downstream comorbidities on ethno‐racial differences in AT(N) plasma biomarkers. This study A) assessed potential differences in plasma Aβ42, Aβ40, Aβ42/40, t‐tau, and NfL among Mexican Americans (MA), non‐Hispanic Blacks (NHB), and non‐Hispanic Whites (NHW); B) determined whether SSDOH and comorbidity factors mediate potential ethno‐racial differences in AD plasma biomarkers. Method Data were obtained from the diverse and well‐characterized Health and Aging Brain Study – Health Disparities (HABS‐HD) and included MAs (n = 931), NHBs (n = 258), and NHWs (n = 942). Group differences in AT(N) plasma biomarkers were assessed using analysis of covariance. Age, sex, and cognitive status (Clinical Dementia Rating Scale Sum of Boxes) were included as covariates. Two multiple mediation models were performed with SSDOH (acculturation, chronic stress, income, area deprivation index) and comorbidity factors (body mass index [BMI], blood pressure, diabetes history) as the potential mediators, respectively. Models accounted for age, sex, and cognitive status, assumed nonlinear relationships, and allowed for mediators to be considered simultaneously. Result Plasma Aβ42 was significantly lower in MAs compared to NHWs (p 0.05). Group differences in plasma Aβ42 were mediated by comorbidity factors (BMI and history of diabetes), but not SSDOH. MAs had greater BMIs and history of diabetes compared to NHWs, both of which were associated with lower plasma Aβ42 levels. SSDOH and comorbidity factors did not mediate group differences in plasma NfL. Conclusion Using a large and diverse community‐based cohort, we demonstrate that ethno‐racial differences in AD‐specific plasma biomarkers are, in part, due to modifiable health and comorbidity factors. This work informs the conditions that give rise to ethno‐racial differences in plasma ATN biomarkers while highlighting potential ethno‐racial disparities in AD research.
What this study adds
Evidence grade: Moderate
The record lists 931 participants. This study assessed ethno-racial differences in plasma amyloid, tau and neurodegeneration biomarkers of Alzheimer's disease and whether structural and social determinants of health and comorbidities mediate these differences. It found that plasma Aβ42 was significantly lower in Mexican Americans compared to non-Hispanic Whites, and that Mexican Americans had greater BMIs and history of diabetes, both associated with lower plasma Aβ42 levels.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Meeker, K. L., Ances, B. M., Petersen, M. E., Barber, R. C., Yaffe, K. S., Zhou, Z., et al. (2023). Effects of structural and social determinants of health and comorbidities on ethno‐racial differences in ATN plasma biomarkers of Alzheimer’s disease: A HABS‐HD study. Alzheimer s & Dementia. https://doi.org/10.1002/alz.078605
Vancouver
Meeker KL, Ances BM, Petersen ME, Barber RC, Yaffe KS, Zhou Z, et al. Effects of structural and social determinants of health and comorbidities on ethno‐racial differences in ATN plasma biomarkers of Alzheimer’s disease: A HABS‐HD study. Alzheimer s & Dementia. 2023. doi:10.1002/alz.078605.
BibTeX
@article{meeker2023-b608ec21,
author = {Meeker, Karin L. and Ances, Beau M. and Petersen, Melissa E. and Barber, Robert C. and Yaffe, Kristine S. and Zhou, Zhengyang and Llibre‐Guerra, Jorge J. and Zhang, Fan and others},
title = {{Effects of structural and social determinants of health and comorbidities on ethno‐racial differences in ATN plasma biomarkers of Alzheimer’s disease: A HABS‐HD study}},
journal = {Alzheimer s \& Dementia},
year = {2023},
doi = {10.1002/alz.078605},
url = {https://doi.org/10.1002/alz.078605}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Result Plasma Aβ42 was significantly lower in MAs compared to NHWs (p 0.05).
- MAs had greater BMIs and history of diabetes compared to NHWs, both of which were associated with lower plasma Aβ42 levels.
Why it matters
This study assessed ethno-racial differences in plasma amyloid, tau and neurodegeneration biomarkers of Alzheimer's disease and whether structural and social determinants of health and comorbidities mediate these differences. It found that plasma Aβ42 was significantly lower in Mexican Americans compared to non-Hispanic Whites, and that Mexican Americans had greater BMIs and history of diabetes, both associated with lower plasma Aβ42 levels.
New to this subject? Start with our plain-English guide: Risk factors, ranked →
Study details
- Participants931
- Evidence strengthModerate
How this study scored 43/100
Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Alzheimer s & Dementia) |
| Journal's citation record | 2 / 4 | Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 3 / 5 | 2023 — within 6 year(s) of the newest study here |
| Sample size | 2 / 4 | 931 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 1 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.2 citations a year over 5 year(s) since 2023 |
| Impact for its field and year | 1 / 6 | Cited 0.2× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Sid E. O’Bryant: h-index 63 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | Washington University in St. Louis: institution h-index 1,962 (OpenAlex) |
| Multicenter collaboration | 3 / 3 | OpenAlex lists 10 institution(s) in 1 country |
| Indexed in PubMed | 1 / 2 | Not in PubMed, but has a DOI |
| Free to read | 2 / 2 | Free to read |
| Total | 43 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Risk factors from nearby years
Also tagged “cerebrospinal”
820 studies in the library carry the topic tag “cerebrospinal”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 820 tagged studies.